Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ANIKAnika Therapeutics, Inc.

Nasdaq · CIK 0000898437
Filer categoryAccelerated filer
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts470

Identity from submissions API

NameAnika Therapeutics, Inc.
CIK0000898437
TickersANIK
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC3841 Surgical & Medical Instruments & Apparatus
EIN043145961
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(781) 457-9000
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ANIKA THERAPEUTICS INC (1997-05-15T00:00:00.000Z → 2014-03-13T00:00:00.000Z)
  • ANIKA RESEARCH INC (1996-07-24T00:00:00.000Z → 1996-11-27T00:00:00.000Z)
Business address
32 WIGGINS AVENUE
BEDFORD
MA
01730
MA
Mailing address
32 WIGGINS AVENUE
BEDFORD
MA
01730
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1098 filing rows loaded from submissions recent; extra archives: CIK0000898437-submissions-001.json (92 filings, 1996-02-22 to 2003-12-18).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 10-Q FORM 10-Q 0001171843-26-007230 001-14027 261531337 34 7080121 1 1
2026-11-06 8-K FORM 8-K 2.02,9.01 0001171843-26-007211 001-14027 261529324 34 443509 1 1
2026-08-07 144 xsl144X01/primary_doc.xml 0001959173-26-005793 001-14027 261255518 33 5294
2026-08-05 4 4 0001193125-26-335269 6083
2026-07-31 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001342 005-45573 261225865 34 7653
2026-07-29 S-8 FORM S-8 0001171843-26-005017 333-297791 261217907 33 192194 1 1
2026-07-29 10-Q FORM 10-Q 0001171843-26-005012 001-14027 261217487 34 7231530 1 1
2026-07-29 8-K FORM 8-K 2.02,9.01 0001171843-26-004977 001-14027 261213959 34 408721 1 1
2026-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000740 005-45573 261182501 34 11027
2026-07-14 8-K FORM 8-K 1.01,2.03,9.01 0001171843-26-004635 001-14027 261174897 34 1616694 1 1
2026-06-23 4 4 0001193125-26-279545 5093
2026-06-23 4 4 0001193125-26-279542 4989
2026-06-23 4 4 0001193125-26-279541 5009
2026-06-23 4 4 0001193125-26-279539 5011
2026-06-23 4 4 0001193125-26-279535 5008
2026-06-23 8-K FORM 8-K 5.02,5.07,9.01 0001171843-26-004253 001-14027 261111038 34 430876 1 1
2026-06-08 DEFA14A DEFA14A 0001140361-26-024374 001-14027 261071210 34 208003
2026-06-05 4 4 0001193125-26-259520 8948
2026-06-01 DEFA14A DEFA14A 0001140361-26-023475 001-14027 261048142 34 39661
2026-05-04 4 4 0001193125-26-202704 5182
2026-04-30 4 4 0001193125-26-197887 5230
2026-04-30 10-Q FORM 10-Q 0001171843-26-002852 001-14027 26919197 34 6002337 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000113 005-45573 26916922 34 7526
2026-04-29 8-K FORM 8-K 2.02,5.02,9.01 0001171843-26-002799 001-14027 26910530 34 408789 1 1
2026-04-28 ARS ARS 0001140361-26-017490 001-14027 26908848 34 8548366
2026-04-28 DEFA14A DEFA14A 0001140361-26-017489 001-14027 26908822 34 3688554
2026-04-28 DEF 14A DEF 14A 0001140361-26-017488 001-14027 26908769 34 11344742 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000682 005-45573 26797815 34 7297
2026-03-23 4 4 0001193125-26-120005 10844
2026-03-17 4 4 0001193125-26-111511 15634
2026-03-17 4 4 0001193125-26-111502 10420
2026-03-17 4 4 0001193125-26-111494 16540
2026-03-17 4 4 0001193125-26-111492 15609
2026-03-11 4 4 0001193125-26-102240 8935
2026-03-11 4 4 0001193125-26-102239 9563
2026-03-11 4 4 0001193125-26-102238 8913
2026-03-03 10-K FORM 10-K 0001171843-26-001275 001-14027 26710193 34 11128695 1 1
2026-02-26 8-K 8-K 2.02,5.02,9.01 0001193125-26-073401 001-14027 26681696 34 406745 1 1
2026-02-03 4 4 0001193125-26-036129 8895
2026-01-27 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-26-000511 005-45573 26567679 34 8674
2026-01-08 8-K 8-K 2.02,5.02,9.01 0001193125-26-007655 001-14027 26519565 34 557346 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-002059 005-45573 26519286 34 21471
2025-11-21 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000902664-25-005133 005-45573 251504807 34 10600
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-108057 005-45573 251460273 34 21206
2025-11-05 S-8 FORM S-8 0001171843-25-007033 333-291282 251453729 33 191923 1 1
2025-11-05 10-Q FORM 10-Q 0001171843-25-007032 001-14027 251453709 34 7445881 1 1
2025-11-05 8-K FORM 8-K 2.02,8.01,9.01 0001171843-25-007003 001-14027 251451767 34 392405 1 1
2025-10-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003599 005-45573 251399669 34 10847
2025-07-30 10-Q FORM 10-Q 0001171843-25-004826 001-14027 251167174 34 7329338 1 1
2025-07-30 8-K FORM 8-K 2.02,9.01 0001171843-25-004810 001-14027 251163956 34 402996 1 1
2025-07-30 8-K FORM 8-K 7.01,9.01 0001171843-25-004809 001-14027 251163945 34 226527 1 1
2025-07-24 UPLOAD filename1.pdf 0000000000-25-007779 001-14027 39801
2025-07-17 CORRESP filename1.htm 0001193125-25-160537 48064
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004072 5058
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004071 5054
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004070 5063
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004069 6082
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004067 5034
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004065 5140
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004064 5053
2025-06-24 4 xslF345X05/ownership.xml 0001171843-25-004063 5058
2025-06-24 8-K FORM 8-K 5.02,5.07,9.01 0001171843-25-004062 001-14027 251069995 34 406553 1 1
2025-06-18 UPLOAD filename1.pdf 0000000000-25-006390 001-14027 46324
2025-06-05 4 xslF345X05/ownership.xml 0001171843-25-003729 9351
2025-05-09 10-Q FORM 10-Q 0001171843-25-003019 001-14027 25929716 34 7106946 1 1
2025-05-09 8-K FORM 8-K 2.02,9.01 0001171843-25-003005 001-14027 25928377 34 343239 1 1
2025-04-28 ARS ARS 0001140361-25-016084 001-14027 25881681 34 1087029
2025-04-28 DEFA14A DEFA14A 0001140361-25-016083 001-14027 25881670 34 2797313
2025-04-28 DEF 14A DEF 14A 0001140361-25-016082 001-14027 25881666 34 10828096 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000696 005-45573 25844633 34 10944
2025-04-11 3 xslF345X02/ownership.xml 0001171843-25-002159 12180
2025-04-10 8-K FORM 8-K 5.02 0001171843-25-002148 001-14027 25828378 34 196239 1 1
2025-03-18 4 xslF345X05/ownership.xml 0001171843-25-001534 14767
2025-03-18 4 xslF345X05/ownership.xml 0001171843-25-001533 8645
2025-03-18 4 xslF345X05/ownership.xml 0001171843-25-001532 14818
2025-03-18 4 xslF345X05/ownership.xml 0001171843-25-001531 15801
2025-03-17 10-K FORM 10-K 0001171843-25-001486 001-14027 25741716 34 10815261 1 1
2025-03-13 4 xslF345X05/ownership.xml 0001171843-25-001470 9161
2025-03-13 4 xslF345X05/ownership.xml 0001171843-25-001468 9210
2025-03-13 4 xslF345X05/ownership.xml 0001171843-25-001467 10185
2025-03-12 8-K FORM 8-K 2.02,9.01 0001171843-25-001437 001-14027 25731818 34 400125 1 1
2025-03-11 4 xslF345X05/ownership.xml 0001171843-25-001406 9383
2025-03-11 4 xslF345X05/ownership.xml 0001171843-25-001405 9473
2025-03-11 4 xslF345X05/ownership.xml 0001171843-25-001404 10447
2025-03-11 8-K FORM 8-K 2.01,7.01,9.01 0001171843-25-001388 001-14027 25725894 34 224472 1 1
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001508 005-45573 25594558 34 11948
2025-01-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000354204-25-000493 005-45573 25549988 34 8802
2024-11-08 SC 13G/A us0352551081_110824.txt 0002012383-24-003689 005-45573 241439846 34 13876
2024-11-04 10-Q FORM 10-Q 0001171843-24-005993 001-14027 241424271 34 6236239 1 1
2024-10-31 8-K FORM 8-K 2.02,9.01 0001171843-24-005923 001-14027 241412424 34 418986 1 1
2024-10-31 8-K FORM 8-K 2.01,7.01,9.01 0001171843-24-005922 001-14027 241412418 34 229842 1 1
2024-10-23 SC 13G/A us0352551081_102324.txt 0002012383-24-001796 005-45573 241389797 34 13864
2024-10-04 4 xslF345X05/ownership.xml 0001171843-24-005510 9355
2024-08-08 10-Q FORM 10-Q 0001171843-24-004615 001-14027 241189693 34 5728488 1 1
2024-08-08 8-K FORM 8-K 2.02,9.01 0001171843-24-004607 001-14027 241188397 34 391302 1 1
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003910 5063
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003909 5059
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003908 5068
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003907 6086
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003906 5039
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003905 5145
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003904 5058
2024-07-11 4 xslF345X05/ownership.xml 0001171843-24-003903 5062
2024-07-11 8-K FORM 8-K 5.07 0001171843-24-003900 001-14027 241112204 34 200964 1 1
2024-06-25 DEFA14A DEFA14A 0001171843-24-003640 001-14027 241069277 34 59784
2024-06-11 ARS ARS 0001193125-24-159222 001-14027 241036658 34 13591865
2024-06-11 DEF 14A DEF 14A 0001193125-24-159219 001-14027 241036637 34 4371064 1 1
2024-06-05 4 xslF345X05/ownership.xml 0001171843-24-003315 5142
2024-06-05 4 xslF345X05/ownership.xml 0001171843-24-003314 7971
2024-06-05 4 xslF345X05/ownership.xml 0001171843-24-003313 5060
2024-06-05 3 xslF345X02/ownership.xml 0001171843-24-003312 9877
2024-06-05 3 xslF345X02/ownership.xml 0001171843-24-003311 9943
2024-06-05 3 xslF345X02/ownership.xml 0001171843-24-003310 9979
2024-05-31 S-8 FORM S-8 0001171843-24-003188 333-279870 241009844 33 190299
2024-05-30 SC 13D/A ANIKA THERAPEUTICS, INC. 0000902664-24-003936 005-45573 241005938 34 74365
2024-05-28 8-K FORM 8-K 1.01,5.02,7.01,9.01 0001171843-24-003136 001-14027 24992908 34 398182 1 1
2024-05-08 10-Q FORM 10-Q 0001171843-24-002682 001-14027 24927518 34 5122531 1 1
2024-05-08 8-K FORM 8-K 5.02,9.01 0001171843-24-002673 001-14027 24926217 34 475905 1 1
2024-05-08 8-K FORM 8-K 2.02,9.01 0001171843-24-002672 001-14027 24926106 34 342830 1 1
2024-04-26 10-K/A FORM 10-K/A 0001171843-24-002274 001-14027 24879052 34 1676289 1 1
2024-04-05 SC 13G/A us0352551081_040424.txt 0001086364-24-007359 005-45573 24825626 34 13610
2024-03-19 4 xslF345X05/ownership.xml 0001171843-24-001461 8140
2024-03-19 4 xslF345X05/ownership.xml 0001171843-24-001460 8138
2024-03-19 4 xslF345X05/ownership.xml 0001171843-24-001459 8092
2024-03-19 4 xslF345X05/ownership.xml 0001171843-24-001458 8139
2024-03-15 10-K FORM 10-K 0001171843-24-001380 001-14027 24753417 34 9524232 1 1
2024-03-13 8-K FORM 8-K 2.02,9.01 0001171843-24-001322 001-14027 24746008 34 401976 1 1
2024-03-12 4 xslF345X05/ownership.xml 0001171843-24-001307 22115
2024-03-12 4 xslF345X05/ownership.xml 0001171843-24-001306 21107
2024-03-12 4 xslF345X05/ownership.xml 0001171843-24-001305 15490
2024-03-12 4 xslF345X05/ownership.xml 0001171843-24-001304 21056
2024-03-06 SC 13D/A ANIKA THERAPEUTICS, INC. 0000902664-24-002242 005-45573 24727727 34 120659
2024-02-26 8-K FORM 8-K 5.02,9.01 0001171843-24-000972 001-14027 24673775 34 188678 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020290 005-45573 24627418 34 13220
2024-02-09 SC 13G/A SC 13G/A 0001104659-24-012716 005-45573 24613005 34 118914
2024-02-09 SC 13G/A SEC SCHEDULE 13G 0000354204-24-003106 005-45573 24612349 34 19626
2024-01-24 SC 13G/A us0352551081_012424.txt 0001086364-24-002362 005-45573 24555935 34 13614
2024-01-22 SC 13G/A Anika_Therapeutics_Inc.txt 0000093751-24-000041 005-45573 24547435 34 8569
2024-01-22 S-8 POS S-8 POS 0001171843-24-000329 333-276622 24547273 33 163432
2024-01-19 S-8 FORM S-8 0001171843-24-000313 333-276622 24546253 33 56085
2024-01-12 3/A xslF345X02/ownership.xml 0001171843-24-000241 4186
2023-11-03 10-Q FORM 10-Q 0001171843-23-006687 001-14027 231373805 34 5857114 1 1
2023-11-02 8-K FORM 8-K 2.02,9.01 0001171843-23-006678 001-14027 231372407 34 380504 1 1
2023-10-06 SC 13G/A us0352551081_100523.txt 0001306550-23-010077 005-45573 231313874 34 13642
2023-10-03 4 xslF345X05/ownership.xml 0001171843-23-006018 9078
2023-09-21 8-K FORM 8-K 7.01,9.01 0001171843-23-005813 001-14027 231267753 34 3929088 1 1
2023-09-11 SC 13D/A ANIKA THERAPEUTICS, INC. 0000902664-23-004717 005-45573 231246567 34 59649
2023-08-17 SC 13D ANIKA THERAPEUTICS, INC. 0000902664-23-004496 005-45573 231179838 34 82242
2023-08-11 4 xslF345X05/ownership.xml 0001171843-23-005271 9326
2023-08-08 S-8 FORM S-8 0001171843-23-005115 333-273812 231152575 33 82088
2023-08-08 10-Q FORM 10-Q 0001171843-23-005114 001-14027 231152528 34 5752171 1 1
2023-08-08 8-K FORM 8-K 2.02,9.01 0001171843-23-005107 001-14027 231151406 34 383878 1 1
2023-06-26 3 xslF345X02/ownership.xml 0001171843-23-004119 12000
2023-06-21 8-K FORM 8-K 5.02,5.07,9.01 0001171843-23-004058 001-14027 231030543 34 412986 1 1
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003963 4959
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003962 4927
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003961 4955
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003960 4964
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003959 4935
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003958 5041
2023-06-16 4 xslF345X04/ownership.xml 0001171843-23-003957 4954
2023-05-09 10-Q FORM 10-Q 0001171843-23-003106 001-14027 23903385 34 5037445 1 1
2023-05-09 8-K FORM 8-K 2.02,9.01 0001171843-23-003096 001-14027 23902097 34 320341 1 1
2023-05-01 ARS ARS 0001193125-23-130734 001-14027 23875292 34 8976276
2023-05-01 DEFA14A DEFA14A 0001193125-23-130728 001-14027 23875211 34 901470
2023-05-01 DEF 14A DEF 14A 0001193125-23-130714 001-14027 23875171 34 7696259 1 1
2023-04-28 4 xslF345X04/ownership.xml 0001171843-23-002685 10105
2023-04-28 8-K 8-K 8.01,9.01 0001193125-23-124376 001-14027 23860261 34 143532 1 1
2023-04-25 PRER14A PRER14A 0001193125-23-115473 001-14027 23845631 34 8088116 1 1
2023-04-17 4 xslF345X04/ownership.xml 0001171843-23-002340 5007
2023-04-17 3 xslF345X02/ownership.xml 0001171843-23-002339 10335
2023-04-13 8-K 8-K 1.01,5.02,7.01,9.01 0001193125-23-100714 001-14027 23819171 34 279442 1 1
2023-04-06 PRRN14A ANIKA THERAPEUTICS, INC. 0000902664-23-002514 001-14027 23807204 34 349161
2023-04-05 UPLOAD filename1.pdf 0000000000-23-003424 50023
2023-04-05 CORRESP filename1.htm 0001193125-23-091830 21950
2023-04-05 PRER14A PRER14A 0001193125-23-091827 001-14027 23801619 34 7508275 1 1
2023-04-04 UPLOAD filename1.pdf 0000000000-23-003384 44338
2023-03-30 PREC14A ANIKA THERAPEUTICS, INC. 0000902664-23-002420 001-14027 23781705 34 1175983
2023-03-27 DEFA14A DEFA14A 0001193125-23-079900 001-14027 23761591 34 22182
2023-03-27 PREC14A PREC14A 0001193125-23-079887 001-14027 23761555 34 7542635 1 1
2023-03-16 10-K FORM 10-K 0001171843-23-001729 001-14027 23738582 34 10769783 1 1
2023-03-14 4 xslF345X03/ownership.xml 0001171843-23-001686 9125
2023-03-14 4 xslF345X03/ownership.xml 0001171843-23-001685 9123
2023-03-14 4 xslF345X03/ownership.xml 0001171843-23-001684 10098
2023-03-10 4 xslF345X03/ownership.xml 0001171843-23-001597 13841
2023-03-10 4 xslF345X03/ownership.xml 0001171843-23-001596 13839
2023-03-10 4 xslF345X03/ownership.xml 0001171843-23-001595 15081
2023-03-07 4 xslF345X03/ownership.xml 0001171843-23-001480 9282
2023-03-06 8-K FORM 8-K 2.02,9.01 0001171843-23-001426 001-14027 23709025 34 360518 1 1
2023-02-21 DFAN14A ANIKA THERAPEUTICS, INC. 0000902664-23-001925 001-14027 23646890 34 611386
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-037748 005-45573 23624147 34 70546
2023-02-10 SC 13G/A SEC SCHEDULE 13G 0000354204-23-001495 005-45573 23610846 34 19521
2023-02-10 SC 13G/A SC 13G/A 0001104659-23-018306 005-45573 23610154 34 119416
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015312 005-45573 23602424 34 13116
2023-02-08 SC 13G/A Anika_Therapeutics_Inc.txt 0000093751-23-000340 005-45573 23597369 34 8579
2023-01-26 SC 13G/A us0352551081_012623.txt 0001306550-23-004306 005-45573 23554550 34 13300
2023-01-20 SC 13G us0352551081_011923.txt 0001306550-23-000614 005-45573 23539198 34 13267
2022-11-09 10-Q FORM 10-Q 0001171843-22-007281 001-14027 221372027 34 5959769 1 1
2022-11-08 8-K FORM 8-K 2.02,9.01 0001171843-22-007233 001-14027 221368978 34 388653 1 1
2022-11-01 8-K FORM 8-K 8.01,9.01 0001171843-22-006969 001-14027 221351485 34 392794 1 1
2022-10-07 SC 13G SC 13G 0001104659-22-106839 005-45573 221298903 34 96908
2022-08-11 4 xslF345X03/ownership.xml 0001171843-22-005617 7502
2022-08-05 S-8 FORM S-8 0001171843-22-005377 333-266550 221138009 33 56014
2022-08-04 10-Q FORM 10-Q 0001171843-22-005368 001-14027 221137522 34 6248102 1 1
2022-08-03 8-K FORM 8-K 2.02,9.01 0001171843-22-005312 001-14027 221132664 34 420852 1 1
2022-06-10 4 xslF345X03/ownership.xml 0001171843-22-004302 4954
2022-06-10 4 xslF345X03/ownership.xml 0001171843-22-004301 4978
2022-06-10 4 xslF345X03/ownership.xml 0001171843-22-004300 4959
2022-06-10 4 xslF345X03/ownership.xml 0001171843-22-004299 4930
2022-06-10 4 xslF345X03/ownership.xml 0001171843-22-004298 4949
2022-06-10 4 xslF345X03/ownership.xml 0001171843-22-004297 4922
2022-06-10 8-K FORM 8-K 5.02,5.07,9.01 0001171843-22-004296 001-14027 221008838 34 401994 1 1
2022-06-09 SC 13G/A NONE 0001567619-22-012601 005-45573 221006150 34 66352
2022-06-03 DEFA14A DEFA14A 0001171843-22-004116 001-14027 22993047 34 17337
2022-06-01 DEFA14A FORM DEFA14A 0001171843-22-004066 001-14027 22986595 34 1260605
2022-06-01 DEFR14A DEFR14A 0001171843-22-004065 001-14027 22986577 34 31960
2022-05-12 4 xslF345X03/ownership.xml 0001171843-22-003615 4561
2022-05-09 DEFA14A DEFA14A 0001171843-22-003457 001-14027 22904764 34 3143050
2022-05-06 10-Q FORM 10-Q 0001171843-22-003350 001-14027 22897954 34 5529971 1 1
2022-05-05 8-K FORM 8-K 2.02,9.01 0001171843-22-003332 001-14027 22896324 34 333350 1 1
2022-04-28 4 xslF345X03/ownership.xml 0001171843-22-002980 8284
2022-04-27 DEF 14A DEF 14A 0001171843-22-002875 001-14027 22860705 34 1780308
2022-04-27 DEFA14A DEFA14A 0001171843-22-002876 001-14027 22860701 34 206770
2022-03-16 4 xslF345X03/ownership.xml 0001171843-22-001915 5082
2022-03-15 4 xslF345X03/ownership.xml 0001171843-22-001906 7864
2022-03-15 4 xslF345X03/ownership.xml 0001171843-22-001905 7866
2022-03-15 4 xslF345X03/ownership.xml 0001171843-22-001903 7865
2022-03-15 4 xslF345X03/ownership.xml 0001171843-22-001878 5037
2022-03-14 4 xslF345X03/ownership.xml 0001171843-22-001833 7051
2022-03-14 4 xslF345X03/ownership.xml 0001171843-22-001832 5081
2022-03-11 4 xslF345X03/ownership.xml 0001171843-22-001812 7307
2022-03-11 4 xslF345X03/ownership.xml 0001171843-22-001811 9041
2022-03-11 4 xslF345X03/ownership.xml 0001171843-22-001810 9085
2022-03-11 4 xslF345X03/ownership.xml 0001171843-22-001809 7311
2022-03-11 10-K FORM 10-K 0001171843-22-001790 001-14027 22730751 34 25952384 1 1
2022-03-08 8-K FORM 8-K 2.02,9.01 0001171843-22-001706 001-14027 22722265 34 411832 1 1
2022-03-07 4 xslF345X03/ownership.xml 0001171843-22-001664 9083
2022-02-28 4 xslF345X03/ownership.xml 0001171843-22-001459 14770
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-040700 005-45573 22628071 34 69127
2022-02-14 SC 13G/A d9177681_13g-a.htm 0000919574-22-001038 005-45573 22623636 34 165119
2022-02-14 SC 13G/A NONE 0001567619-22-003727 005-45573 22623478 34 66361
2022-02-11 4 xslF345X03/ownership.xml 0001171843-22-000984 6912
2022-02-10 SC 13G/A anik-13g_20211231.txt 0001037389-22-000010 005-45573 22613480 34 13482
2022-02-10 SC 13G/A ANIKA_THERAPEUTICS_INC.txt 0000093751-22-000145 005-45573 22613164 34 8584
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016488 005-45573 22606361 34 13112
2022-02-08 SC 13G/A SEC SCHEDULE 13G 0000354204-22-001660 005-45573 22601190 34 19520
2022-01-27 SC 13G/A us0352551081_012722.txt 0000834237-22-002382 005-45573 22562379 34 13271
2022-01-26 SC 13G us0352551081_012522.txt 0000834237-22-000902 005-45573 22555255 34 13262
2021-11-15 8-K FORM 8-K 1.01,2.03,9.01 0001171843-21-007914 001-14027 211406412 34 2024252 1 1
2021-11-05 S-8 FORM S-8 0001171843-21-007627 333-260821 211384505 33 60706
2021-11-05 10-Q FORM 10-Q 0001171843-21-007580 001-14027 211381439 34 6632661 1 1
2021-11-04 8-K FORM 8-K 2.02,9.01 0001171843-21-007565 001-14027 211380064 34 405655 1 1
2021-11-01 4 xslF345X03/ownership.xml 0001171843-21-007368 4891
2021-11-01 3 xslF345X02/ownership.xml 0001171843-21-007367 9509
2021-11-01 8-K FORM 8-K 5.02,7.01,9.01 0001171843-21-007366 001-14027 211368434 34 224255 1 1
2021-08-13 4 xslF345X03/ownership.xml 0001171843-21-005933 7041
2021-08-12 4 xslF345X03/ownership.xml 0001171843-21-005897 7286
2021-08-06 S-8 S-8 0001171843-21-005596 333-258530 211149838 33 60850
2021-08-06 S-8 S-8 0001171843-21-005595 333-258529 211149835 33 43264
2021-08-06 10-Q FORM 10-Q 0001171843-21-005594 001-14027 211149832 34 5616470 1 1
2021-08-05 8-K FORM 8-K 2.02,9.01 0001171843-21-005577 001-14027 211148289 34 367977 1 1
2021-07-12 4 xslF345X03/ownership.xml 0001171843-21-004833 8834
2021-06-30 8-K FORM 8-K 8.01 0001171843-21-004630 001-14027 211062780 34 188824 1 1
2021-06-22 8-K FORM 8-K 5.02,5.07,9.01 0001171843-21-004469 001-14027 211035531 34 474528 1 1
2021-06-21 4 xslF345X03/ownership.xml 0001171843-21-004431 4955
2021-06-21 4 xslF345X03/ownership.xml 0001171843-21-004430 4923
2021-06-21 4 xslF345X03/ownership.xml 0001171843-21-004429 4951
2021-06-21 4 xslF345X03/ownership.xml 0001171843-21-004428 4960
2021-06-21 4 xslF345X03/ownership.xml 0001171843-21-004427 4812
2021-06-21 4 xslF345X03/ownership.xml 0001171843-21-004426 4931
2021-06-17 4 xslF345X03/ownership.xml 0001171843-21-004397 6889
2021-05-20 4 xslF345X03/ownership.xml 0001171843-21-003679 5042
2021-05-14 4 xslF345X03/ownership.xml 0001171843-21-003534 4906
2021-05-07 10-Q FORM 10-Q 0001171843-21-003272 001-14027 21899259 34 5413983 1 1
2021-05-06 8-K FORM 8-K 2.02,9.01 0001171843-21-003263 001-14027 21897851 34 314737 1 1
2021-04-30 DEFA14A DEFA14A 0001171843-21-002977 001-14027 21878606 34 194678
2021-04-30 DEF 14A DEF 14A 0001171843-21-002976 001-14027 21878475 34 1973780
2021-04-28 4 xslF345X03/ownership.xml 0001171843-21-002890 7284
2021-04-26 10-K/A FORM 10-K/A 0001171843-21-002766 001-14027 21854732 34 10904285 1 1
2021-03-11 4 xslF345X03/ownership.xml 0001171843-21-001712 7841
2021-03-11 4 xslF345X03/ownership.xml 0001171843-21-001711 7864
2021-03-11 4 xslF345X03/ownership.xml 0001171843-21-001710 7818
2021-03-11 4 xslF345X03/ownership.xml 0001171843-21-001709 7862
2021-03-11 4 xslF345X03/ownership.xml 0001171843-21-001708 7863
2021-03-08 4 xslF345X03/ownership.xml 0001171843-21-001598 7100
2021-03-05 10-K FORM 10-K 0001171843-21-001573 001-14027 21719601 34 11698763 1 1
2021-03-04 8-K FORM 8-K 2.02,9.01 0001171843-21-001546 001-14027 21714244 34 434257 1 1
2021-03-01 4 xslF345X03/ownership.xml 0001171843-21-001429 7511
2021-03-01 4 xslF345X03/ownership.xml 0001171843-21-001428 14949
2021-02-16 SC 13G d8798973_13-g.htm 0000919574-21-001359 005-45573 21634702 34 169895
2021-02-12 SC 13G/A SEC SCHEDULE 13G 0000354204-21-000284 005-45573 21626872 34 19529
2021-02-12 SC 13G SC 13G 0001193125-21-040398 005-45573 21623504 34 73761
2021-02-11 SC 13G/A NONE 0001567619-21-002826 005-45573 21615385 34 66369
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-017444 005-45573 21609996 34 13983
2021-02-10 SC 13G anik-13g_20201231.txt 0001037389-21-000005 005-45573 21609678 34 13449
2021-02-05 SC 13G Anika_Therapeutics_Inc.txt 0000093751-21-000074 005-45573 21594621 34 8556
2021-01-25 SC 13G/A us0352551081_012521.txt 0000834237-21-000670 005-45573 21550496 34 13247
2020-11-12 4 xslF345X03/ownership.xml 0001171843-20-007934 4908
2020-11-05 10-Q FORM 10-Q 0001171843-20-007600 001-14027 201288122 34 7835278 1 1
2020-11-04 8-K FORM 8-K 2.02,9.01 0001171843-20-007581 001-14027 201286794 34 412461 1 1
2020-11-03 4 xslF345X03/ownership.xml 0001171843-20-007517 5070
2020-10-21 8-K FORM 8-K 8.01,9.01 0001171843-20-007136 001-14027 201250654 34 229838 1 1
2020-09-08 4 xslF345X03/ownership.xml 0001171843-20-006337 4993
2020-09-08 4 xslF345X03/ownership.xml 0001171843-20-006336 4983
2020-09-08 3 xslF345X02/ownership.xml 0001171843-20-006335 3068
2020-09-08 3 xslF345X02/ownership.xml 0001171843-20-006334 3047
2020-09-08 8-K FORM 8-K 5.02,7.01,9.01 0001171843-20-006332 001-14027 201164907 34 242535 1 1
2020-08-17 SC 13G/A NONE 0001567619-20-015623 005-45573 201109670 34 66365
2020-08-12 4 xslF345X03/ownership.xml 0001171843-20-005857 7681
2020-08-12 3 xslF345X02/ownership.xml 0001171843-20-005856 3026
2020-08-07 10-Q FORM 10-Q 0001171843-20-005715 001-14027 201084027 34 7547858 1 1
2020-08-06 10-Q/A FORM 10-Q/A 0001171843-20-005655 001-14027 201081549 34 40404
2020-08-05 8-K FORM 8-K 5.02,7.01,9.01 0001171843-20-005566 001-14027 201078455 34 98157
2020-08-05 SC 13G/A NONE 0001567619-20-014322 005-45573 201078026 34 66365
2020-07-30 8-K FORM 8-K 2.02,9.01 0001171843-20-005415 001-14027 201061510 34 189199
2020-07-10 4 xslF345X03/ownership.xml 0001171843-20-004894 6590
2020-06-19 S-8 S-8 0001171843-20-004454 333-239304 20975667 33 45263
2020-06-18 8-K FORM 8-K 5.02,5.07,9.01 0001171843-20-004425 001-14027 20972501 34 198706
2020-06-02 8-K FORM 8-K 5.02,7.01,9.01 0001171843-20-004133 001-14027 20936970 34 18454
2020-05-22 10-Q FORM 10-Q 0001171843-20-003962 001-14027 20906728 34 4984700 1
2020-05-08 8-K FORM 8-K 8.01 0001171843-20-003513 001-14027 20858090 34 26552
2020-05-07 8-K FORM 8-K 2.02,9.01 0001171843-20-003473 001-14027 20856301 34 131558
2020-04-29 8-K FORM 8-K 1.01,5.02,7.01,9.01 0001171843-20-003020 001-14027 20830484 34 150694
2020-04-29 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001171843-20-003017 001-14027 20830368 34 4284925
2020-04-29 DEF 14A DEF 14A 0001171843-20-003014 001-14027 20830232 34 1642541
2020-04-28 4 xslF345X03/ownership.xml 0001171843-20-002971 11437
2020-04-08 8-K FORM 8-K 2.03,9.01 0001171843-20-002483 001-14027 20782063 34 23703
2020-03-13 8-K/A FORM 8-K/A 9.01 0001171843-20-001713 001-14027 20712645 34 800603
2020-03-13 8-K/A FORM 8-K/A 9.01 0001171843-20-001712 001-14027 20712640 34 355256
2020-03-06 4 xslF345X03/ownership.xml 0001171843-20-001547 7671
2020-03-06 3 xslF345X02/ownership.xml 0001171843-20-001546 3023
2020-03-06 10-K FORM 10-K 0001171843-20-001536 001-14027 20692468 34 6631369 1
2020-03-02 8-K FORM 8-K 5.02,9.01 0001171843-20-001415 001-14027 20676786 34 54634
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001364 6687
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001363 9042
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001362 5636
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001361 4882
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001360 4887
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001359 5118
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001358 9073
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001357 6236
2020-02-27 4 xslF345X03/ownership.xml 0001171843-20-001356 4850
2020-02-20 8-K FORM 8-K 2.02,9.01 0001171843-20-001133 001-14027 20635055 34 217650
2020-02-19 SEC STAFF LETTER filename1.pdf 9999999997-20-000800 227620
2020-02-14 8-K FORM 8-K 5.02,7.01,9.01 0001171843-20-000991 001-14027 20619409 34 25839
2020-02-14 SC 13G/A NONE 0001567619-20-003430 005-45573 20612675 34 66368
2020-02-13 SC 13G AnikaTherapeuticsInc.txt 0000093751-20-000414 005-45573 20608564 34 8672
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001104659-20-018686 005-45573 20601719 34 13802
2020-02-12 SC 13G/A SCHEDULE 13G/A 0001258897-20-000780 005-45573 20600967 34 53082
2020-02-06 4 xslF345X03/ownership.xml 0001171843-20-000783 5102
2020-02-04 SC 13G/A us0352551081_020320.txt 0000834237-20-001600 005-45573 20571430 34 13285
2020-02-03 8-K FORM 8-K 2.01,8.01,9.01 0001171843-20-000664 001-14027 20569047 34 26917
2020-01-31 SEC STAFF LETTER filename1.pdf 9999999997-20-000410 230927
2020-01-30 8-K FORM 8-K 5.02,7.01,9.01 0001171843-20-000604 001-14027 20561423 34 24640
2020-01-24 8-K FORM 8-K 2.01,8.01,9.01 0001171843-20-000472 001-14027 20545479 34 25567
2020-01-07 8-K FORM 8-K 1.01,9.01 0001171843-20-000105 001-14027 20513375 34 1256000
2020-01-06 8-K ANIKA THERAPEUTICS, INC. 8-K 8.01,9.01 0001157523-20-000024 001-14027 20510717 34 40014
2019-11-29 4 xslF345X03/ownership.xml 0001171843-19-007869 5023
2019-11-08 4 xslF345X03/ownership.xml 0001171843-19-007390 11102
2019-11-01 4 xslF345X03/ownership.xml 0001171843-19-007081 5011
2019-10-28 10-Q FORM 10-Q 0001171843-19-006886 001-14027 191173881 34 3819921 1
2019-10-25 8-K ANIKA THERAPEUTICS, INC. 8-K 2.02,9.01 0001157523-19-002103 001-14027 191166675 34 307403
2019-08-30 4 xslF345X03/ownership.xml 0001171843-19-005733 4938
2019-08-22 4 xslF345X03/ownership.xml 0001171843-19-005617 4976
2019-08-12 4 xslF345X03/ownership.xml 0001171843-19-005414 4900
2019-07-30 4 xslF345X03/ownership.xml 0001171843-19-004979 4623
2019-07-30 4 xslF345X03/ownership.xml 0001171843-19-004978 5038
2019-07-26 10-Q FORM 10-Q 0001171843-19-004913 001-14027 19978592 34 3595913 1
2019-07-24 8-K ANIKA THERAPEUTICS, INC. 8-K 2.02,9.01 0001157523-19-001572 001-14027 19971001 34 309184
2019-07-10 8-K FORM 8-K 5.02 0001171843-19-004502 001-14027 19949395 34 134463
2019-07-09 4 xslF345X03/ownership.xml 0001171843-19-004474 7651
2019-07-09 3 xslF345X02/ownership.xml 0001171843-19-004473 210680
2019-06-26 8-K FORM 8-K 5.02 0001171843-19-004182 001-14027 19921669 34 14923
2019-06-21 S-8 FORM S-8 0001171843-19-004107 333-232254 19911579 33 48195
2019-06-20 8-K FORM 8-K 5.02,5.07,9.01 0001171843-19-004087 001-14027 19908605 34 189521
2019-05-13 8-K FORM 8-K 1.01,8.01 0001171843-19-003311 001-14027 19818418 34 21349
2019-05-06 10-Q FORM 10-Q 0001171843-19-002946 001-14027 19797709 34 2957468 1
2019-05-02 8-K ANIKA THERAPEUTICS, INC. 8-K 2.02,9.01 0001157523-19-001056 001-14027 19791898 34 106780
2019-04-25 DEFA14A DEFA14A 0001171843-19-002642 001-14027 19767535 34 978494
2019-04-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001171843-19-002640 001-14027 19767429 34 1738808
2019-04-12 8-K FORM 8-K 5.02,9.01 0001171843-19-002383 001-14027 19746320 34 236078
2019-03-26 8-K FORM 8-K 5.02 0001171843-19-001983 001-14027 19705344 34 16308
2019-03-01 4 xslF345X03/ownership.xml 0001171843-19-001414 4552
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001392 4881
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001391 4850
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001390 4887
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001389 6691
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001388 8349
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001387 8360
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001386 8705
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001385 8386
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001384 4837
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001383 4869
2019-02-28 4 xslF345X03/ownership.xml 0001171843-19-001382 8409
2019-02-27 10-K FORM 10-K 0001171843-19-001243 001-14027 19635510 34 6361140 1
2019-02-21 8-K ANIKA THERAPEUTICS, INC. 8-K 2.02,9.01 0001157523-19-000413 001-14027 19621863 34 155183
2019-02-12 SC 13G/A NONE 0001567619-19-003279 005-45573 19591327 34 66370
2019-02-12 SC 13G/A SEC SCHEDULE 13G 0000902219-19-000124 005-45573 19588079 34 33101
2019-02-11 SC 13G/A anikatherapeuticsinc.htm 0000932471-19-004316 005-45573 19582075 34 34292
2019-02-08 SC 13G/A SCHEDULE 13G/A 0001258897-19-001335 005-45573 19577876 34 53142

Latest XBRL company facts

One latest value per concept from companyfacts (470 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 13.40M 2026-10-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
dei EntityPublicFloat Entity Public Float USD 147.34M 2025-06-30 2025 FY 10-K 2026-03-03 0001171843-26-001275
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 113.00M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 645,195 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.34M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 120 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.08M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.89M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 21 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017488
ffd NetFeeAmt NetFeeAmt USD 1,066.04 2026-07-28 S-8 2026-07-29 0001171843-26-005017
ffd TtlFeeAmt TtlFeeAmt USD 1,066.04 2026-07-28 S-8 2026-07-29 0001171843-26-005017
ffd TtlOfferingAmt TtlOfferingAmt USD 7.72M 2026-07-28 S-8 2026-07-29 0001171843-26-005017
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-28 S-8 2026-07-29 0001171843-26-005017
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.03M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 24.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 24.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 20.69M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 7.96M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001171843-18-003806
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AccruedRentCurrent Accrued Rent, Current USD 231,000 2016-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 1.82M 2014-06-30 2014 Q2 10-Q 2014-08-04 0001171843-14-003693
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 55.54M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD -6.07M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -5.42M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 67.39M 2013-06-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 84.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 27,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 11.68M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 647,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001171843-19-001243
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 640,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AllowanceForDoubtfulAccountsReceivableChargeOffs Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) USD 135,353 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 640,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 369,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 417,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AmortizationOfAcquiredIntangibleAssets Amortization of Acquired Intangible Assets (Deprecated 2013-01-31) USD 519,982 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-06 0001157523-13-002386
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -25,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001171843-21-002766
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.10M 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap AreaOfLand Area of Land sqft 26,000 2009-12-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2020-07-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001171843-20-007600
us-gaap Assets Assets USD 189.60M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AssetsCurrent Assets, Current USD 103.05M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 7.15M 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 22.01M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 699 2014-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax USD 0 2018-09-30 2018 Q3 10-Q 2018-10-26 0001171843-18-007266
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 1,391 2015-09-30 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 22.01M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -22.98M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 134.41M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 2.15M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 16.90M 2021-06-30 2021 Q2 10-Q 2021-08-06 0001171843-21-005594
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-11 0001171843-22-001790
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 918,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CapitalizedComputerSoftwareAccumulatedAmortization Capitalized Computer Software, Accumulated Amortization USD 0 2024-09-30 2024 Q3 10-Q 2024-11-04 0001171843-24-005993
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 220,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-05 0001171843-21-007580
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 105,300 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 44.96M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 6.39M 2017-12-31 2018 Q3 10-Q 2018-10-26 0001171843-18-007266
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -91.63M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-22 0001171843-20-003962
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 44.96M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -12.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 5.50M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001171843-20-007600
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 90.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 15.72M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 13.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CommonStockValue Common Stock, Value, Issued USD 134,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 1 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 22.70M 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap ConstructionPayableCurrent Construction Payable, Current USD 804,000 2016-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 261,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 33.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 27.36M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap CostsAndExpenses Costs and Expenses USD 62.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 248,000 2017-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 176,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 250,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 611,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 185,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.013 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-05 0001171843-13-004422
us-gaap DebtInstrumentInterestRateAtPeriodEnd Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) pure 0.014 2013-09-30 2013 Q3 10-Q 2013-11-05 0001171843-13-004422
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 74,000 2008-02-01 2008-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 7.46M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net USD 171,000 2008-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 61,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 925,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 329,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 12.16M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 0 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap DeferredRevenue Deferred Revenue USD 126,702 2014-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 33,948 2015-09-30 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 48,000 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 19.99M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 23,854 2014-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 776,000 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 59.02M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.56M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 1.27M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 13.44M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 1.41M 2015-09-30 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 392,005 2010-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 13.29M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 1.81M 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 515,000 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 1.18M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.63M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 819,000 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 45.58M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 4.44M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-05 0001171843-14-002144
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 4.99M 2022-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 4.73M 2019-09-30 2019 Q3 10-Q 2019-10-28 0001171843-19-006886
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 6.03M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 362,150 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 600,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap Depreciation Depreciation USD 4.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.27M 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 3.29M 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent Disposal Group, Including Discontinued Operation, Accounts Payable, Current USD 797,000 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents USD 1.53M 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 3.63M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001171843-25-003019
us-gaap DisposalGroupIncludingDiscontinuedOperationInventory1 Disposal Group, Including Discontinued Operation, Inventory USD 221,000 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Current USD 3.32M 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets Disposal Group, Including Discontinued Operation, Prepaid and Other Assets USD 89,000 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment USD 1.13M 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 700,000 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap EarlyRepaymentOfSeniorDebt Early Repayment of Senior Debt USD 8.40M 2013-11-01 2013-11-30 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.167 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.002 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 371,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.003 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.064 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 400,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-28 0001171843-19-006886
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.117 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.022 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.013 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0.025 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent pure 0.001 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -31,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-22 0001171843-20-003962
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 8.69M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 5.50M 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD 647,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap ExcessTaxBenefitFromShareBasedCompensationOperatingActivities Excess Tax Benefit from Share-based Compensation, Operating Activities USD 647,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 22,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001171843-20-007600
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 2.49M 2021-09-30 2021 Q3 10-Q 2021-11-05 0001171843-21-007580
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 356,000 2020-12-31 2020 FY 10-K/A 2021-04-26 0001171843-21-002766
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-11 0001171843-22-001790
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 132,000 2022-06-30 2022 Q2 10-Q 2022-08-04 0001171843-22-005368
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2021-12-31 2021 FY 10-K 2022-03-11 0001171843-22-001790
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2022-06-30 2022 Q2 10-Q 2022-08-04 0001171843-22-005368
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 0 2022-06-30 2022 Q2 10-Q 2022-08-04 0001171843-22-005368
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 43,000 2022-06-30 2022 Q2 10-Q 2022-08-04 0001171843-22-005368
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 66,000 2022-06-30 2022 Q2 10-Q 2022-08-04 0001171843-22-005368
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 2,000 2022-06-30 2022 Q2 10-Q 2022-08-04 0001171843-22-005368
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0 2022-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 10.68M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 600,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 2.80M 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 200,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001171843-25-003019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 11,000 2025-06-30 2025 Q2 10-Q 2025-07-30 0001171843-25-004826
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.00M 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 32,000 2024-09-30 2024 Q3 10-Q 2024-11-04 0001171843-24-005993
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 182,000 2024-09-30 2024 Q3 10-Q 2024-11-04 0001171843-24-005993
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 150,000 2025-03-31 2025 Q1 10-Q 2025-05-09 0001171843-25-003019
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 11,000 2025-06-30 2025 Q2 10-Q 2025-07-30 0001171843-25-004826
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 1.13M 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 126,284 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -6,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -13,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001171843-21-002766
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 300,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001171843-25-003019
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 166,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap Goodwill Goodwill USD 7.78M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001171843-22-001790
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 62.19M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap GoodwillForeignCurrencyTranslationGainLoss Goodwill, Foreign Currency Translation Gain (Loss) USD -273,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 0 2019-11-30 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2025-01-01 2025-11-30 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap GoodwillTranslationAdjustments Goodwill, Translation Adjustments (Deprecated 2016-01-31) USD -857,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap GrossProfit Gross Profit USD 59.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 697,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 2.46M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 300,000 2012-10-01 2012-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -10.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 940,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 3.01M 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001157523-12-002604
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeTaxesPaid Income Taxes Paid USD 993,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001171843-21-002766
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 295,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -2.30M 2017-12-22 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount USD 1.90M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001171843-20-007600
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 43,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1.50M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001171843-24-005993
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -124,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 591,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 207,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 416,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -455,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 645,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 958,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 541,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.09M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-01 0001171843-16-012756
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -50,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 5.91M 2014-04-01 2014-06-30 2014 Q2 10-Q 2014-08-04 0001171843-14-003693
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 14.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.08M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -708,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -25,497 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IncreaseDecreaseInPrepaidTaxes Increase (Decrease) in Prepaid Taxes USD 1.20M 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-05-03 0001171843-16-009632
us-gaap IncrementalCommonSharesAttributableToContingentlyIssuableShares Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares shares 500,000 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 738,687 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends shares 54,124 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 15.74M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 1.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 126,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap InventoryAdjustments Inventory Adjustments USD 3.50M 2018-12-31 2018 FY 10-K 2019-02-27 0001171843-19-001243
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 4.41M 2014-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 8.09M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InventoryNet Inventory, Net USD 30.35M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 3.07M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 6.84M 2014-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 13.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InventoryRecallExpense Inventory Recall Expense USD 1.10M 2018-01-01 2018-12-31 2020 FY 10-K/A 2021-04-26 0001171843-21-002766
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 3.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 2.33M 2014-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 11.41M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InventoryWriteDown Inventory Write-down USD 3.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 1.07M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-10-28 0001171843-19-006886
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.80M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001171843-19-001243
us-gaap LeaseCost Lease, Cost USD 3.83M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 27.80M 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 18.80M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.85M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.77M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.77M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.77M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.77M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 720,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001171843-22-007281
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6.49M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 189.60M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap LiabilitiesCurrent Liabilities, Current USD 26.73M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 4.78M 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 16.00M 2008-01-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap LongTermDebt Long-term Debt USD 9.60M 2012-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 1.60M 2012-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 1.60M 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 6.40M 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 6.40M 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.60M 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 25.00M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001171843-20-007600
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 27.46M 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 25.77M 2026-03-31 2026 Q1 10-Q 2026-04-30 0001171843-26-002852
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -11.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 209,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-28 0001171843-17-004447
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -4.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -8.42M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-28 0001171843-17-004447
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 21.73M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-07-28 0001171843-17-004447
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 50.54M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 16.66M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1 Noncash or Part Noncash Divestiture, Amount of Consideration Received USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap NumberOfReportingUnits Number of Reporting Units pure 2 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001171843-22-007281
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 26.25M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.58M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 24.57M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.98M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 25.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 8.70M 2018-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.88M 2018-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 414,000 2018-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.67M 2018-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.92M 2018-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.92M 2018-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 4.70M 2013-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.037 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 7.50M 2019-12-31 2019 FY 10-K 2020-03-06 0001171843-20-001536
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.93M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -1,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-01 0001171843-16-012756
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD 756,461 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001157523-12-002604
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -458,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -88,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) USD -519,405 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 548,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-01 0001171843-16-012756
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 431 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 733,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD -105,300 2010-01-01 2010-09-30 2011 Q3 10-Q 2011-11-04 0001157523-11-006495
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 9.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 74,000 2009-01-01 2009-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 1.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 4.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.48M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PrepaidTaxes Prepaid Taxes USD 412,301 2014-12-31 2015 Q3 10-Q 2015-11-03 0001171843-15-005922
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 294,106 2014-04-01 2014-06-30 2014 Q2 10-Q 2014-08-04 0001171843-14-003693
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-15 0001171843-24-001380
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProceedsFromSaleOfNotesReceivable Proceeds from Sale of Notes Receivable USD 266,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProceedsFromSaleOfOtherAssets1 Proceeds from Sale of Other Assets USD 530,865 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-06 0001171843-14-005281
us-gaap ProceedsFromSaleOfOtherAssetsInvestingActivities Proceeds from Sale of Other Assets, Investing Activities USD 188,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 246,785 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 187,735 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 12,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 198,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProductWarrantyExpense Product Warranty Expense USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-04 0001171843-15-002462
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 9.80M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 96.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 40.74M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 312,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 21.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RestructuringCharges Restructuring Charges USD 2.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RestructuringCosts Restructuring Costs USD 2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 2.50M 2012-10-01 2012-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap RestructuringReserve Restructuring Reserve USD 1.18M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RestructuringReserveAccrualAdjustment Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) USD 287,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 8,384 2014-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap RestructuringReserveSettledWithCash Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) USD 630,804 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-06 0001157523-13-002386
us-gaap RestructuringReserveTranslationAdjustment Restructuring Reserve, Foreign Currency Translation Gain (Loss) USD -1,589 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 58.73M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 92.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 78.60M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-10-26 0001171843-18-007266
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 121,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 107.78M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap SalesRevenueGoodsNetPercentage Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) pure 1 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 113.42M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 5.64M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-27 0001171843-18-001450
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 40.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 3.25M 2023-03-31 2023 Q1 10-Q 2023-05-09 0001171843-23-003106
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 134,041 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 23.09 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 569,042 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 14.85 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 953,713 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 20.41 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 317,850 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 203,485 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 25.86 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.416 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-07-29 0001171843-26-005012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-07-29 0001171843-26-005012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.007 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.006 2013-01-01 2013-06-30 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 650,000 2013-05-19 2013-06-18 2013 Q2 10-Q 2013-08-06 0001157523-13-003914
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 900,000 2022-03-31 2022 Q1 10-Q 2022-05-06 0001171843-22-003350
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 102,000 2024-09-30 2024 Q3 10-Q 2024-11-04 0001171843-24-005993
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-01-01 2025-06-30 2025 Q3 10-Q 2025-11-05 0001171843-25-007032
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value USD/shares 30 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001171843-25-001486
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 340,315 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 16,300 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 12.71 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 31.42 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1,000 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.77M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 32.07 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 248,000 2024-09-30 2024 Q3 10-Q 2024-11-04 0001171843-24-005993
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.77M 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 31.42 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 290,704 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 32.6 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 34.51 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate pure 0.012 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-04 0001171843-15-002462
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 248,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 137.58M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockIssued1 Stock Issued USD 16.82M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 198,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 833 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 16.82M 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-13 0001157523-12-001365
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 261,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 0 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-16 0001171843-23-001729
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 76,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 12,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 133,774 2014-04-01 2014-06-30 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 6.35M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-24 0001171843-17-001121
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 3.97M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 852,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap StockRepurchaseProgramAuthorizedAmount1 Stock Repurchase Program, Authorized Amount USD 50.00M 2019-05-02 2021 FY 10-K 2022-03-11 0001171843-22-001790
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap TaxBenefitFromStockOptionsExercised Tax Benefit from Stock Options Exercised (Deprecated 2012-01-31) USD -394,076 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-07 0001157523-12-002604
us-gaap TaxBenefitFromStockOptionsExercised1 Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) USD 64,642 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-06 0001157523-13-002386
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 300,000 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 3,089 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-14 0001157523-13-001397
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 38,329 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-13 0001171843-14-001240
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 38,329 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-13 0001171843-15-001395
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 56,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-10 0001171843-16-008487
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001171843-26-001275
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-07-29 0001171843-26-005012
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 13.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 14.28M 2020-10-01 2020-12-31 2020 FY 10-K/A 2021-04-26 0001171843-21-002766
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 13.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001171843-26-007230

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →